Myofibroblast YAP/TAZ is dispensable for liver fibrosis in mice

被引：7
|
作者：
Xu, Liran [1 ]
Wettschureck, Nina [2 ,3 ]
Bai, Yongping [4 ]
Yuan, Zuyi [5 ]
Wang, Shengpeng [1 ,2 ,5 ]
机构：
[1] Xi An Jiao Tong Univ, Hlth Sci Ctr, Key Lab Environm & Genes Related Dis, Cardiovasc Res Ctr,Sch Basic Med Sci, Xian, Peoples R China
[2] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany
[3] Goethe Univ, Ctr Mol Med, Frankfurt, Germany
[4] Cent South Univ, Xiangya Hosp, Dept Geriatr Med, Changsha, Peoples R China
[5] Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 1, West Yanta Rd 277, Xian 710061, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷 / 01期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.jhep.2021.02.026
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：238 / 241
页数：5
相关论文
共 50 条
  • [1] Reply to: "Myofibroblast YAP/TAZ is dispensable for liver fibrosis in mice"
    Liu, Yuan
    Xu, Ning
    Ji, Xiaofeng
    JOURNAL OF HEPATOLOGY, 2021, 75 (01) : 241 - 241
  • [2] Yap/Taz Activity Drive Liver Fibrosis
    Yimlamai, Dean
    Fowl, Brendan
    Softic, Samir
    Camargo, Fernando D.
    GASTROENTEROLOGY, 2016, 150 (04) : S1165 - S1165
  • [3] Myofibroblast YAP/TAZ activation is a key in
    He, Xiaolin
    Tolosa, Monica F.
    Zhang, Tianzhou
    Goru, Santosh Kumar
    Severino, Luisa Ulloa
    Misra, Paraish S.
    McEvoy, Caitriona M.
    Caldwell, Lauren
    Szeto, Stephen G.
    Gao, Feng
    Chen, Xiaolan
    Atin, Cassandra
    Ki, Victoria
    Vukosa, Noah
    Hu, Catherine
    Zhang, Johnny
    Yip, Christopher
    Krizova, Adriana
    Wrana, Jeffrey L.
    Yuen, Darren A.
    JCI INSIGHT, 2022, 7 (04)
  • [4] YAP and TAZ are dispensable for physiological and malignant haematopoiesis
    Elisa Donato
    Francesca Biagioni
    Andrea Bisso
    Marieta Caganova
    Bruno Amati
    Stefano Campaner
    Leukemia, 2018, 32 : 2037 - 2040
  • [5] YAP and TAZ are dispensable for physiological and malignant haematopoiesis
    Donato, Elisa
    Biagioni, Francesca
    Bisso, Andrea
    Caganova, Marieta
    Amati, Bruno
    Campaner, Stefano
    LEUKEMIA, 2018, 32 (09) : 2037 - 2040
  • [6] Distinct roles of YAP/TAZ in myofibroblast transformation
    Raghunathan, VijayKrishna
    Rose, Brad W.
    Thomasy, Sara M.
    Russell, Paul
    Murphy, Christopher J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [7] YAP and TAZ are distinct effectors of corneal myofibroblast transformation
    Muppala, Santoshi
    Raghunathan, Vijay Krishna
    Jalilian, Iman
    Thomasy, Sara
    Murphy, Christopher J.
    EXPERIMENTAL EYE RESEARCH, 2019, 180 : 102 - 109
  • [8] Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice
    Alsamman, Sarah
    Christenson, Stephanie A.
    Yu, Amy
    Ayad, Nadia M. E.
    Mooring, Meghan S.
    Segal, Joe M.
    Hu, Jimmy Kuang-Hsien
    Schaub, Johanna R.
    Ho, Steve S.
    Rao, Vikram
    Marlow, Megan M.
    Turner, Scott M.
    Sedki, Mai
    Pantano, Lorena
    Ghoshal, Sarani
    Ferreira, Diego Dos Santos
    Ma, Hsiao-Yen
    Duwaerts, Caroline C.
    Espanol-Suner, Regina
    Wei, Lan
    Newcomb, Benjamin
    Mileva, Izolda
    Canals, Daniel
    Hannun, Yusuf A.
    Chung, Raymond T.
    Mattis, Aras N.
    Fuchs, Bryan C.
    Tager, Andrew M.
    Yimlamai, Dean
    Weaver, Valerie M.
    Mullen, Alan C.
    Sheppard, Dean
    Chen, Jennifer Y.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (557)
  • [9] The role of YAP/TAZ in the pathogenesis of skin fibrosis
    Lu, L.
    Gao, N.
    Ma, X.
    Liu, Z.
    Wang, X.
    Yang, S.
    Han, G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S105 - S105
  • [10] YAP/TAZ Signaling in the Pathobiology of Pulmonary Fibrosis
    Papavassiliou, Kostas A.
    Sofianidi, Amalia A.
    Spiliopoulos, Fotios G.
    Gogou, Vassiliki A.
    Gargalionis, Antonios N.
    Papavassiliou, Athanasios G.
    CELLS, 2024, 13 (18)
12345